Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Albumin-bound paclitaxel|DRUG: Carboplatin|DRUG: Herceptin®
Sponsor: Celgene